Product NDC: | 0409-4857 |
Proprietary Name: | Fosphenytoin Sodium |
Non Proprietary Name: | FOSPHENYTOIN SODIUM |
Active Ingredient(s): | 50 mg/mL & nbsp; FOSPHENYTOIN SODIUM |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-4857 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078158 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110708 |
Package NDC: | 0409-4857-10 |
Package Description: | 10 VIAL, GLASS in 1 CARTON (0409-4857-10) > 10 mL in 1 VIAL, GLASS |
NDC Code | 0409-4857-10 |
Proprietary Name | Fosphenytoin Sodium |
Package Description | 10 VIAL, GLASS in 1 CARTON (0409-4857-10) > 10 mL in 1 VIAL, GLASS |
Product NDC | 0409-4857 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | FOSPHENYTOIN SODIUM |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20110708 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | FOSPHENYTOIN SODIUM |
Strength Number | 50 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |